Global Licensing agreement

Article

UK firm UltraVision CLPL has agreed on a global licensing agreement with Bausch + Lomb for the marketing and sales of KeraSoft contact lens.

UK firm UltraVision CLPL has agreed on a global licensing agreement with Bausch + Lomb for the marketing and sales of KeraSoft contact lens.

The move will enable UltraVision to distribute the lens globally and reach a wider market. Jerry Warner, Vice President of marketing and general manager at Bausch + Lomb, Global Contact Lens, said: "Extending the KeraSoft technology allows the lab to expand the ability of practitioners to offer life-changing vision correction to a wider range of patients who have a variety of irregular cornea conditions resulting from keratoconus and pellucid marginal degeneration."

The custom-made soft lens has been manufactured from silicone hydrogel materials and has been developed to correct irregular corneas, pellucid marginal degeneration and keratoconus.

Joseph Barr, vice president of Global Clinical and Medical Affairs and Professional Services, Vision Care, Bausch + Lomb, said: “This technology has totally transformed my view of contact lens management of keratoconus and irregular cornea patients. The visual results and enhancement of life are true advances.”

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.